Kerri-Ann Millar
Chief Financial Officer
Other
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $463,000 | $1,044,784 |
| 2023 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $444,181 | $1,162,538 |
| 2022 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $418,459 | $1,056,925 |
| 2021 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $374,231 | $1,358,011 |
| 2020 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $292,500 | $2,194,633 |
| 2019 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $215,000 | $448,321 |
Executive changes
Earnings-call appearances
-
Cue Biopharma, Inc. Q4 FY2023 Earnings Call2023-12-31
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q3 FY2023 Earnings Call2023-09-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q2 FY2023 Earnings Call2023-06-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q4 FY2022 Earnings Call2022-12-31
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q3 FY2022 Earnings Call2022-09-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q2 FY2022 Earnings Call2022-06-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q2 FY2021 Earnings Call2021-06-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q1 FY2021 Earnings Call2021-03-31
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q4 FY2020 Earnings Call2020-12-31
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q2 FY2020 Earnings Call2020-06-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q1 FY2020 Earnings Call2020-05-19
Cue Biopharma, Inc. (CUE)